Background With the rising global prevalence of fatty liver disease related to metabolic
dysfunction, the association of this common liver condition with chronic kidney disease …

Nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic
liver disease worldwide, affecting up to~ 30% of adult populations. NAFLD defines a …

Simple Summary Multifactorial diseases are caused by a combination of genetic and
environmental factors and various risk factors that accumulate with age. Cardiovascular …

Fatty liver disease is an emerging contributor to disease burden worldwide. The past
decades of work established the heterogeneous nature of non-alcoholic fatty liver disease …

Glomerular hyperfiltration (GH) is an increase in the glomerular filtration rate, possibly
progressing to chronic kidney disease (CKD). Metabolic-associated steatotic liver disease …

Over recent years, the nomenclature of non-alcoholic fatty liver disease has undergone
significant changes. Indeed, in 2020, an expert consensus panel proposed the term …

Abstract Background and Aims We examined the impact of a co‐diagnosis of metabolic
dysfunction‐associated steatotic liver disease (MASLD) and type 2 diabetes (T2D) on …

Background Metabolic dysfunction‐associated fatty liver disease (MAFLD, 2020 diagnostic
criteria) and glomerular hyperfiltration share common risk factors, including obesity, insulin …

Circulating fatty acid composition is assumed to play an important role in metabolic
dysfunction-associated fatty liver disease (MAFLD) pathogenesis. This study aimed to …

The aim of the second edition of our Special Issue, entitled “Nonalcoholic Fatty Liver
Disease/Metabolic Associated Fatty Liver Disease: New Insights 2.0”, is to report the recent …